{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T12:23:36Z","timestamp":1783772616192,"version":"3.55.0"},"reference-count":142,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00109-025-02635-9","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T01:10:03Z","timestamp":1767661803000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The role of ferroptosis in renal cell carcinoma: molecular mechanisms and therapeutic implications"],"prefix":"10.1007","volume":"104","author":[{"given":"Zhihong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Depei","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3513-9646","authenticated-orcid":false,"given":"Wuran","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"issue":"1","key":"2635_CR1","volume":"12","author":"DC Feng","year":"2025","unstructured":"Feng DC, Li DX, Wu RC, Wang J, Xiao YH, Yoo KH, Ye X, Wei WR, Kong DP, Tuo ZT (2025) Global burden and cross-country inequalities in urinary tumors from 1990 to 2021 and predicted incidence changes to 2046. Mil Med Res 12(1)","journal-title":"Mil Med Res"},{"issue":"9669","key":"2635_CR2","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/S0140-6736(09)60229-4","volume":"373","author":"BI Rini","year":"2009","unstructured":"Rini BI, Campbell SC, Escudier B (2009) Renal cell carcinoma. Lancet 373(9669):1119\u20131132","journal-title":"Lancet"},{"key":"2635_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/mdr2.70031","author":"X Zhu","year":"2025","unstructured":"Zhu X, Che X, Yang R, Bao B, Chu G (2025) Global, regional, and national burden of cancer in the elderly population, 1990\u20132021: analysis of data from the global burden of disease study 2021. Med Research. https:\/\/doi.org\/10.1002\/mdr2.70031","journal-title":"Med Research"},{"issue":"1","key":"2635_CR4","volume":"11","author":"H Zi","year":"2024","unstructured":"Zi H, Liu MY, Luo LS, Huang Q, Luo PC, Luan HH, Huang J, Wang DQ, Wang YB, Zhang YY, Yu RP, Li YT, Zheng H, Liu TZ, Fan Y, Zeng XT (2024) Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021. Mil Med Res 11(1)","journal-title":"Mil Med Res"},{"issue":"8","key":"2635_CR5","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1158\/2159-8290.CD-18-1354","volume":"9","author":"WM Linehan","year":"2019","unstructured":"Linehan WM, Schmidt LS, Crooks DR, Wei D, Srinivasan R, Lang M, Ricketts CJ (2019) The metabolic basis of kidney cancer. Cancer Discov 9(8):1006\u20131021","journal-title":"Cancer Discov"},{"issue":"6","key":"2635_CR6","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.euo.2019.09.002","volume":"2","author":"AW Hahn","year":"2019","unstructured":"Hahn AW, Klaassen Z, Agarwal N, Haaland B, Esther J, Ye XY, Wang X, Pal SK, Wallis CJD (2019) First-line treatment of metastatic renal cell carcinoma: a systematic review and network meta-analysis. Eur Urol Oncol 2(6):708\u2013715","journal-title":"Eur Urol Oncol"},{"issue":"4","key":"2635_CR7","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M (2021) Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 22(4):266\u2013282","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"8","key":"2635_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13644","volume":"57","author":"L Yu","year":"2024","unstructured":"Yu L, Huang K, Liao Y, Wang L, Sethi G, Ma Z (2024) Targeting novel regulated cell death: ferroptosis, pyroptosis and necroptosis in anti-PD-1\/PD-L1 cancer immunotherapy. Cell Prolif 57(8)","journal-title":"Cell Prolif"},{"issue":"2","key":"2635_CR9","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/mdr2.70020","volume":"1","author":"M Yan","year":"2025","unstructured":"Yan M, Zhang J, Ji G, Fang X, Mo C (2025) Ferroptosis in pneumoconiosis: from molecular and cellular mechanisms to therapeutic strategies. Med Research 1(2):239\u2013256","journal-title":"Med Research"},{"key":"2635_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/burnst\/tkad051","volume":"12","author":"Z Wei","year":"2024","unstructured":"Wei Z, Yu H, Zhao H, Wei M, Xing H, Pei J, Yang Y, Ren K (2024) Broadening horizons: ferroptosis as a new target for traumatic brain injury. Burns Trauma 12","journal-title":"Burns Trauma"},{"issue":"4","key":"2635_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/wsbm.1644","volume":"16","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Zou L, Li X, Guo L, Hu B, Ye H, Liu Y (2024) SLC40A1 in iron metabolism, ferroptosis, and disease: a review. WIREs Mechanisms of Disease 16(4)","journal-title":"WIREs Mechanisms of Disease"},{"issue":"1","key":"2635_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1515\/jtim-2025-0004","volume":"13","author":"Z Guo","year":"2025","unstructured":"Guo Z, Liu Y, Chen D, Sun Y, Li D, Meng Y, Zhou Q, Zeng F, Deng G, Chen X (2025) Targeting regulated cell death: apoptosis, necroptosis, pyroptosis, ferroptosis, and cuproptosis in anticancer immunity. J Transl Intern Med 13(1):10\u201332","journal-title":"J Transl Intern Med"},{"issue":"1","key":"2635_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02457-w","volume":"24","author":"Q Deng","year":"2025","unstructured":"Deng Q, Ji Y, Liu J, Wen T (2025) Lipid reprogramming and ferroptosis crosstalk in clear cell renal cell carcinoma: metabolic vulnerabilities and therapeutic targeting. Mol Cancer 24(1)","journal-title":"Mol Cancer"},{"issue":"3","key":"2635_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13779","volume":"58","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Li J, Liu J, Gao Y, Li K, Zhao X, Liu Y, Wang D, Hu X, Wang Z (2025) Ferroptosis in osteoarthritis: towards novel therapeutic strategy. Cell Prolif 58(3)","journal-title":"Cell Prolif"},{"issue":"7","key":"2635_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2024.03.001","volume":"14","author":"M Zhang","year":"2024","unstructured":"Zhang M, Guo M, Gao Y, Wu C, Pan X, Huang Z (2024) Mechanisms and therapeutic targets of ferroptosis: implications for nanomedicine design. J Pharm Anal 14(7)","journal-title":"J Pharm Anal"},{"key":"2635_CR16","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cancergen.2025.06.009","volume":"296-297","author":"G Baskar","year":"2025","unstructured":"Baskar G (2025) GPX4 in triple-negative breast cancer: a key regulator of ferroptosis and therapeutic target. Cancer Genet 296\u2013297:76\u201383. https:\/\/doi.org\/10.1016\/j.cancergen.2025.06.009","journal-title":"Cancer Genet"},{"issue":"24","key":"2635_CR17","doi-asserted-by":"publisher","first-page":"9078","DOI":"10.1002\/cam4.4395","volume":"10","author":"F Xu","year":"2021","unstructured":"Xu F, Guan Y, Xue L, Zhang P, Li M, Gao M, Chong T (2021) The roles of ferroptosis regulatory gene SLC7A11 in renal cell carcinoma: a multi-omics study. Cancer Med 10(24):9078\u20139096","journal-title":"Cancer Med"},{"issue":"5","key":"2635_CR18","first-page":"2615","volume":"16","author":"M Mezzanotte","year":"2024","unstructured":"Mezzanotte M, Stanga S (2024) Brain iron dyshomeostasis and ferroptosis in Alzheimer\u2019s disease pathophysiology: two faces of the same coin. Aging Dis 16(5):2615\u20132640","journal-title":"Aging Dis"},{"issue":"1-2","key":"2635_CR19","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji AF, Clish CB, Brown LM, Girotti AW, Cornish VW, Schreiber SL, Stockwell BR (2014) Regulation of ferroptotic cancer cell death by GPX4. Cell 156(1\u20132):317\u2013331","journal-title":"Cell"},{"issue":"1","key":"2635_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09277-9","volume":"10","author":"Y Zou","year":"2019","unstructured":"Zou Y, Palte MJ, Deik AA, Li H, Eaton JK, Wang W, Tseng YY, Deasy R, Kost-Alimova M, Dancik V, Leshchiner ES, Viswanathan VS, Signoretti S, Choueiri TK, Boehm JS, Wagner BK, Doench JG, Clish CB, Clemons PA, Schreiber SL (2019) A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis. Nat Commun 10(1)","journal-title":"Nat Commun"},{"issue":"1","key":"2635_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s40170-022-00290-z","volume":"10","author":"TD Klasson","year":"2022","unstructured":"Klasson TD, LaGory EL, Zhao H, Huynh SK, Papandreou I, Moon EJ, Giaccia AJ (2022) ACSL3 regulates lipid droplet biogenesis and ferroptosis sensitivity in clear cell renal cell carcinoma. Cancer Metab 10(1)","journal-title":"Cancer Metab"},{"issue":"1","key":"2635_CR22","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2025.2567815","volume":"26","author":"S Wang","year":"2025","unstructured":"Wang S, Wang Y, Liu B, Zhang D, Zhang Z, Yang H, Li G, Zhao X, Liu J, Li Q, Song Y, Zhang Y, Wang Y, Zhou H (2025) Loss of ACSL1 fuels ferroptosis resistance in clear cell renal carcinoma. Cancer Biol Ther 26(1)","journal-title":"Cancer Biol Ther"},{"issue":"3","key":"2635_CR23","doi-asserted-by":"publisher","first-page":"322","DOI":"10.21147\/j.issn.1000-9604.2024.03.08","volume":"36","author":"Z Fan","year":"2024","unstructured":"Fan Z, Dong S, Wang N, Khawar MB, Wang J, Sun H (2024) Unlocking epigenetics for precision treatment of Ewing\u2019s sarcoma. Chin J Cancer Res 36(3):322\u2013340","journal-title":"Chin J Cancer Res"},{"key":"2635_CR24","doi-asserted-by":"publisher","DOI":"10.2174\/1874467217666230914090621","volume":"17","author":"DV Lim","year":"2024","unstructured":"Lim DV, Woo WH, Lim JX, Loh XY, Soh HT, Lim SYA, Lee ZY, Yow HY, Hamzah SB, Sellappans R, Foo JB (2024) Targeting mutant-p53 for cancer treatment: are we there yet? Curr Mol Pharmacol 17","journal-title":"Curr Mol Pharmacol"},{"key":"2635_CR25","doi-asserted-by":"publisher","DOI":"10.1177\/15330338221078728","volume":"21","author":"CL Ye","year":"2022","unstructured":"Ye CL, Du Y, Yu X, Chen ZY, Wang L, Zheng YF, Liu XH (2022) STEAP3 affects ferroptosis and progression of renal cell carcinoma through the p53\/xCT pathway. Technol Cancer Res Treat 21","journal-title":"Technol Cancer Res Treat"},{"issue":"1","key":"2635_CR26","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2353115","volume":"2022","author":"Y Li","year":"2022","unstructured":"Li Y, Zhang Y, Qiu Q, Wang L, Mao H, Hu J, Chen Z, Du Y, Liu X (2022) Energy-stress-mediated AMPK activation promotes GPX4-dependent ferroptosis through the JAK2\/STAT3\/P53 axis in renal cancer. Oxid Med Cell Longev 2022(1)","journal-title":"Oxid Med Cell Longev"},{"issue":"10","key":"2635_CR27","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1016\/j.celrep.2019.07.107","volume":"28","author":"WH Yang","year":"2019","unstructured":"Yang WH, Ding CC, Sun T, Rupprecht G, Lin CC, Hsu D, Chi JT (2019) The Hippo pathway effector TAZ regulates ferroptosis in renal cell carcinoma. Cell Rep 28(10):2501\u20132508","journal-title":"Cell Rep"},{"key":"2635_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7560569","volume":"2022","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Li Y, Qiu Q, Chen Z, Du Y, Liu X (2022) MITD1 deficiency suppresses clear cell renal cell carcinoma growth and migration by inducing ferroptosis through the TAZ\/SLC7A11 pathway. Oxid Med Cell Longev 2022. https:\/\/doi.org\/10.1155\/2022\/7560569","journal-title":"Oxid Med Cell Longev"},{"key":"2635_CR29","doi-asserted-by":"publisher","unstructured":"Nusrat S, Din RU, Tariq MA, Yang H. Epigenetic dysregulation and osteocyte senescence: convergent drivers of osteosarcopenia in aging bone and muscle. Aging Dis. 2025. Epub 20250613. https:\/\/doi.org\/10.14336\/AD.2025.0370. PubMed PMID: 40540718.","DOI":"10.14336\/AD.2025.0370"},{"issue":"10","key":"2635_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2024.101012","volume":"14","author":"S Ouyang","year":"2024","unstructured":"Ouyang S, Zeng Z, He J, Luo L (2024) Epigenetic regulation of targeted ferroptosis: a new strategy for drug development. J Pharm Anal 14(10)","journal-title":"J Pharm Anal"},{"issue":"8","key":"2635_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06057-8","volume":"14","author":"W Xue","year":"2023","unstructured":"Xue W, Jian W, Meng Y, Wang T, Cai L, Yu Y, Yu Y, Xia Z, Zhang C (2023) Knockdown of SETD2 promotes erastin-induced ferroptosis in ccRCC. Cell Death Dis 14(8)","journal-title":"Cell Death Dis"},{"issue":"2","key":"2635_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2024.114149","volume":"441","author":"G Hong","year":"2024","unstructured":"Hong G, Chen W, Gong M, Wu Y, Shu G, Xiao Y, Zhang T, ShuXiong X (2024) KAT7 suppresses tumorigenesis in clear cell renal cell carcinoma (ccRCC) by regulating cell cycle and ferroptosis sensitivity. Exp Cell Res 441(2)","journal-title":"Exp Cell Res"},{"key":"2635_CR33","doi-asserted-by":"publisher","DOI":"10.34133\/research.0789","volume":"8","author":"M Zhang","year":"2025","unstructured":"Zhang M, Liu H, Yin R, Xu J, Fan S, Qian X, Cao M, Li S, Zhang A, Chen G, Yong H, Li Z, Bai J (2025) PRMT5-mediated arginine methylation of ACSL4 attenuates its stability and suppresses ferroptosis in renal cancer. Research 8","journal-title":"Research"},{"key":"2635_CR34","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cancergen.2023.12.006","volume":"282","author":"A Ghorbani","year":"2024","unstructured":"Ghorbani A, Hosseinie F, Khorshid Sokhangouy S, Islampanah M, Khojasteh-Leylakoohi F, Maftooh M, Nassiri M, Hassanian SM, Ghayour-Mobarhan M, Ferns GA, Khazaei M, Nazari E, Avan A (2024) The prognostic, diagnostic, and therapeutic impact of long noncoding RNAs in gastric cancer. Cancer Genet 282:14\u201326. https:\/\/doi.org\/10.1016\/j.cancergen.2023.12.006","journal-title":"Cancer Genet"},{"key":"2635_CR35","volume":"17","author":"S Hu","year":"2024","unstructured":"Hu S, Yan J, Yuan Q, Meng T, Cai Z, Huang Y, Wang Y (2024) The role of miRNAs in podocyte injury in diabetic nephropathy: mechanisms and clinical applications. Curr Mol Pharmacol 17","journal-title":"Curr Mol Pharmacol"},{"key":"2635_CR36","doi-asserted-by":"publisher","unstructured":"Zhang H, Tao T, Ji J, Zhao T, Sun S, Zhang L, Wu J, Chen M, Chen S, Xu B, Mao W. CircPVT1 promotes lung metastasis and tumor progression in renal cell carcinoma by encoding the cP104aa peptide and targeting EIF4A3. Adv Sci (Weinh). 2025:e01211. Epub 20250918. https:\/\/doi.org\/10.1002\/advs.202501211. PubMed PMID: 40966379.","DOI":"10.1002\/advs.202501211"},{"key":"2635_CR37","doi-asserted-by":"publisher","DOI":"10.2174\/0118761429249717230920113227","volume":"17","author":"A Keshavarzmotamed","year":"2024","unstructured":"Keshavarzmotamed A, Mousavi V, Masihipour N, Rahmati A, Mousavi Dehmordi R, Ghezelbash B, Alimohammadi M, Mafi A (2024) Regulating miRNAs expression by resveratrol: novel insights based on molecular mechanism and strategies for cancer therapy. Curr Mol Pharmacol 17","journal-title":"Curr Mol Pharmacol"},{"key":"2635_CR38","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4213401","volume":"2022","author":"C Zhu","year":"2022","unstructured":"Zhu C, Song Z, Chen Z, Lin T, Lin H, Xu Z, Ai F, Zheng S (2022) MicroRNA-4735-3p facilitates ferroptosis in clear cell renal cell carcinoma by targeting SLC40A1. Anal Cell Pathol (Amst) 2022. https:\/\/doi.org\/10.1155\/2022\/4213401","journal-title":"Anal Cell Pathol (Amst)"},{"key":"2635_CR39","doi-asserted-by":"publisher","DOI":"10.1177\/15330338221077803","volume":"21","author":"YZ Li","year":"2022","unstructured":"Li YZ, Zhu HC, Du Y, Zhao HC, Wang L (2022) Silencing lncRNA SLC16A1-AS1 induced ferroptosis in renal cell carcinoma through miR-143-3p\/SLC7A11 signaling. Technol Cancer Res Treat 21","journal-title":"Technol Cancer Res Treat"},{"key":"2635_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.140602","volume":"304","author":"Q Tao","year":"2025","unstructured":"Tao Q, Li Y, Zhang W, Zhang M, Li X, Jin H, Zheng J, Li Y (2025) Long non-coding RNA ZFAS1 promotes ferroptosis by regulating the miR-185-5p\/SLC25A28 axis in clear cell renal cell carcinoma. Int J Biol Macromol 304","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"2635_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02122-8","volume":"24","author":"Y Wang","year":"2025","unstructured":"Wang Y, Yang T, Li Q, Zheng Z, Liao L, Cen J, Chen W, Luo J, Xu Y, Zhou M, Zhang J (2025) circASAP1 induces renal clear cell carcinoma ferroptosis by binding to HNRNPC and thereby regulating GPX4. Mol Cancer 24(1)","journal-title":"Mol Cancer"},{"key":"2635_CR42","doi-asserted-by":"publisher","DOI":"10.2174\/0118761429308361240823061634","volume":"17","author":"L Qiong","year":"2024","unstructured":"Qiong L, Shuyao X, Shan X, Qian F, Jiaying T, Yao X, Hui L (2024) Recent advances in the glycolytic processes linked to tumor metastasis. Curr Mol Pharmacol 17","journal-title":"Curr Mol Pharmacol"},{"key":"2635_CR43","doi-asserted-by":"publisher","DOI":"10.1093\/burnst\/tkad047","volume":"12","author":"Z Wang","year":"2024","unstructured":"Wang Z, Zhao F, Xu C, Zhang Q, Ren H, Huang X, He C, Ma J, Wang Z (2024) Metabolic reprogramming in skin wound healing. Burns Trauma 12","journal-title":"Burns Trauma"},{"issue":"3","key":"2635_CR44","first-page":"1155","volume":"15","author":"Q Huang","year":"2024","unstructured":"Huang Q, Wang Y, Chen S, Liang F (2024) Glycometabolic reprogramming of microglia in neurodegenerative diseases: insights from neuroinflammation. Aging Dis 15(3):1155\u20131175","journal-title":"Aging Dis"},{"issue":"40","key":"2635_CR45","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.1038\/s41388-018-0315-z","volume":"37","author":"H Miess","year":"2018","unstructured":"Miess H, Dankworth B, Gouw AM, Rosenfeldt M, Schmitz W, Jiang M, Saunders B, Howell M, Downward J, Felsher DW, Peck B, Schulze A (2018) The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma. Oncogene 37(40):5435\u20135450","journal-title":"Oncogene"},{"key":"2635_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11050329","author":"JK Meier","year":"2021","unstructured":"Meier JK, Schnetz M, Beck S, Schmid T, Dominguez M, Kalinovic S, Daiber A, Brune B, Jung M (2021) Iron-bound lipocalin-2 protects renal cell carcinoma from ferroptosis. Metabolites. https:\/\/doi.org\/10.3390\/metabo11050329","journal-title":"Metabolites"},{"issue":"1","key":"2635_CR47","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/cas.15175","volume":"113","author":"Z Cheng","year":"2022","unstructured":"Cheng Z, Akatsuka S, Li GH, Mori K, Takahashi T, Toyokuni S (2022) Ferroptosis resistance determines high susceptibility of murine A\/J strain to iron-induced renal carcinogenesis. Cancer Sci 113(1):65\u201378","journal-title":"Cancer Sci"},{"issue":"1","key":"2635_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-02137-6","volume":"10","author":"B Feng","year":"2024","unstructured":"Feng B, Su W, Guo X, Ding T, Duan Y, Hu L, Yu M (2024) MDH2 regulates the sensitivity of clear cell renal cell carcinoma to ferroptosis through its interaction with FSP1. Cell Death Discov 10(1)","journal-title":"Cell Death Discov"},{"issue":"42","key":"2635_CR49","doi-asserted-by":"publisher","first-page":"4709","DOI":"10.1038\/s41388-022-02460-1","volume":"41","author":"YS Green","year":"2022","unstructured":"Green YS, Ferreira Dos Santos MC, Fuja DG, Reichert EC, Campos AR, Cowman SJ, Acuna Pilarte K, Kohan J, Tripp SR, Leibold EA, Sirohi D, Agarwal N, Liu X, Koh MY (2022) ISCA2 inhibition decreases HIF and induces ferroptosis in clear cell renal cell carcinoma. Oncogene 41(42):4709\u20134723","journal-title":"Oncogene"},{"key":"2635_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114098","volume":"148","author":"Z Yan","year":"2025","unstructured":"Yan Z, Li Y, Wang M, Xu K, Liu Y, Wang L, Luo H, Chen Z, Liu X (2025) O-GlcNAcylation of DJ-1 suppresses ferroptosis in renal cell carcinoma by affecting the transsulfuration pathway. Int Immunopharmacol 148","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"2635_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07848-x","volume":"16","author":"H Yang","year":"2025","unstructured":"Yang H, Zhang Z, Feng N, Zhao K, Zhang Y, Yin X, Zhu G, Wang Z, Yan X, Li X, Li Z, Wang Q, Qi Y, Zhao P, He T, Wang K (2025) Cenpt prevents renal cell carcinoma against ferroptosis by enhancing the synthesis of glutathione. Cell Death Dis 16(1)","journal-title":"Cell Death Dis"},{"issue":"1","key":"2635_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2025.114497","volume":"447","author":"F Liu","year":"2025","unstructured":"Liu F, Wang M, Li G, Cheng S, Yu J, Luo H, Zhu X (2025) Krm2 promotes renal cell carcinoma progression and inhibits ferroptosis by interacting with ATF2. Exp Cell Res 447(1)","journal-title":"Exp Cell Res"},{"issue":"5","key":"2635_CR53","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00109-025-02543-y","volume":"103","author":"Z Lyu","year":"2025","unstructured":"Lyu Z, Wang H, Dai F, Lin Y, Wen H, Liu X, Feng X, Xu Z, Huang L (2025) Increased ZNF83 is a potential prognostic biomarker and regulates oxidative stress-induced ferroptosis in clear cell renal cell carcinoma. J Mol Med (Berl) 103(5):583\u2013597","journal-title":"J Mol Med (Berl)"},{"issue":"7","key":"2635_CR54","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1038\/s41418-023-01176-3","volume":"30","author":"S Wang","year":"2023","unstructured":"Wang S, Wang T, Zhang X, Cheng S, Chen C, Yang G, Wang F, Wang R, Zhang Q, Yang D, Zhang Y, Liu S, Qin H, Liu Q, Liu H (2023) The deubiquitylating enzyme USP35 restricts regulated cell death to promote survival of renal clear cell carcinoma. Cell Death Differ 30(7):1757\u20131770","journal-title":"Cell Death Differ"},{"issue":"7-8","key":"2635_CR55","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s10495-024-01953-6","volume":"29","author":"Z Li","year":"2024","unstructured":"Li Z, Tian Y, Zong H, Wang X, Li D, Keranmu A, Xin S, Ye B, Bai R, Chen W, Yang G, Ye L, Wang S (2024) Deubiquitinating enzyme OTUD4 stabilizes RBM47 to induce ATF3 transcription: a novel mechanism underlying the restrained malignant properties of ccRCC cells. Apoptosis 29(7\u20138):1051\u20131069","journal-title":"Apoptosis"},{"issue":"3","key":"2635_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05719-x","volume":"14","author":"L Kang","year":"2023","unstructured":"Kang L, Wang D, Shen T, Liu X, Dai B, Zhou D, Shen H, Gong J, Li G, Hu Y, Wang P, Mi X, Zhang Y, Tan X (2023) PDIA4 confers resistance to ferroptosis via induction of ATF4\/SLC7A11 in renal cell carcinoma. Cell Death Dis 14(3)","journal-title":"Cell Death Dis"},{"issue":"1","key":"2635_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2025.114409","volume":"445","author":"F Huang","year":"2025","unstructured":"Huang F, Ling H, Wang J (2025) Silencing of APEX1 triggers ferroptosis in clear cell renal cell carcinoma via APP-mediated activation of p53\/xCT signaling. Exp Cell Res 445(1)","journal-title":"Exp Cell Res"},{"issue":"1","key":"2635_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-10302-2","volume":"22","author":"Q Gong","year":"2022","unstructured":"Gong Q, Guo Z, Sun W, Du X, Jiang Y, Liu F (2022) CX3CL1 promotes cell sensitivity to ferroptosis and is associated with the tumor microenvironment in clear cell renal cell carcinoma. BMC Cancer 22(1)","journal-title":"BMC Cancer"},{"key":"2635_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2021.09.014","volume":"522","author":"Y Lu","year":"2021","unstructured":"Lu Y, Qin H, Jiang B, Lu W, Hao J, Cao W, Du L, Chen W, Zhao X, Guo H (2021) KLF2 inhibits cancer cell migration and invasion by regulating ferroptosis through GPX4 in clear cell renal cell carcinoma. Cancer Lett 522:1\u201313","journal-title":"Cancer Lett"},{"issue":"6","key":"2635_CR60","doi-asserted-by":"publisher","first-page":"468","DOI":"10.20517\/cdr.2023.29","volume":"6","author":"WJE Frye","year":"2023","unstructured":"Frye WJE, Huff LM, Gonzalez Dalmasy JM, Salazar P, Carter RM, Gensler RT, Esposito D, Robey RW, Ambudkar SV, Gottesman MM (2023) The multidrug resistance transporter P-glycoprotein confers resistance to ferroptosis inducers. Cancer Drug Resist 6(6):468\u2013480","journal-title":"Cancer Drug Resist"},{"issue":"7826","key":"2635_CR61","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41586-020-2732-8","volume":"585","author":"Y Zou","year":"2020","unstructured":"Zou Y, Henry WS, Ricq EL, Graham ET, Phadnis VV, Maretich P, Paradkar S, Boehnke N, Deik AA, Reinhardt F, Eaton JK, Ferguson B, Wang W, Fairman J, Keys HR, Dancik V, Clish CB, Clemons PA, Hammond PT, Boyer LA, Weinberg RA, Schreiber SL (2020) Plasticity of ether lipids promotes ferroptosis susceptibility and evasion. Nature 585(7826):603\u2013608","journal-title":"Nature"},{"key":"2635_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.176110","volume":"960","author":"X Ni","year":"2023","unstructured":"Ni X, Ye C, Yu X, Zhang Y, Hou Y, Zheng Q, Chen Z, Wang L, Weng X, Yang C, Liu X (2023) Overcoming the compensatory increase in NRF2 induced by NPL4 inhibition enhances disulfiram\/copper-induced oxidative stress and ferroptosis in renal cell carcinoma. Eur J Pharmacol 960","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"2635_CR63","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1158\/2159-8290.CD-20-1453","volume":"11","author":"SK Tan","year":"2021","unstructured":"Tan SK, Mahmud I, Fontanesi F, Puchowicz M, Neumann CKA, Griswold AJ, Patel R, Dispagna M, Ahmed HH, Gonzalgo ML, Brown JM, Garrett TJ, Welford SM (2021) Obesity-dependent adipokine chemerin suppresses fatty acid oxidation to confer ferroptosis resistance. Cancer Discov 11(8):2072\u20132093","journal-title":"Cancer Discov"},{"issue":"8077","key":"2635_CR64","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41586-025-09162-0","volume":"644","author":"D Calhoon","year":"2025","unstructured":"Calhoon D, Sang L, Ji F, Bezwada D, Hsu SC, Cai F, Kim N, Basu A, Wu R, Pimentel A, Brooks B, La K, Paulina Serrano A, Cassidy DL, Cai L, Toffessi-Tcheuyap V, Moussa ME, Uritboonthai W, Hoang LT, Kolli M, Jackson B, Margulis V, Siuzdak G, Brugarolas J, Corbin I, Pratt DA, Weiss RJ, DeBerardinis RJ, Birsoy K, Garcia-Bermudez J (2025) Glycosaminoglycan-driven lipoprotein uptake protects tumours from ferroptosis. Nature 644(8077):799\u2013808","journal-title":"Nature"},{"issue":"2","key":"2635_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03482-5","volume":"12","author":"PH Chen","year":"2021","unstructured":"Chen PH, Wu J, Xu Y, Ding CC, Mestre AA, Lin CC, Yang WH, Chi JT (2021) Zinc transporter ZIP7 is a novel determinant of ferroptosis. Cell Death Dis 12(2). https:\/\/doi.org\/10.1038\/s41419-021-03482-5","journal-title":"Cell Death Dis"},{"issue":"8","key":"2635_CR66","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/annonc\/mdj133","volume":"17","author":"P Schoffski","year":"2006","unstructured":"Schoffski P, Dumez H, Clement P, Hoeben A, Prenen H, Wolter P, Joniau S, Roskams T, Van Poppel H (2006) Emerging role of tyrosine kinase inhibitors in the treatment of advanced renal cell cancer: a review. Ann Oncol 17(8):1185\u20131196","journal-title":"Ann Oncol"},{"issue":"2","key":"2635_CR67","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.eururo.2024.10.019","volume":"87","author":"R Barragan-Carrillo","year":"2025","unstructured":"Barragan-Carrillo R, Saad E, Saliby RM, Sun M, Albiges L, Bex A, Heng D, Mejean A, Motzer RJ, Plimack ER, Powles T, Rini BI, Zhang T, Choueiri TK (2025) First and second-line treatments in metastatic renal cell carcinoma. Eur Urol 87(2):143\u2013154","journal-title":"Eur Urol"},{"issue":"23","key":"2635_CR68","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1158\/0008-5472.CAN-22-4001","volume":"83","author":"K Chang","year":"2023","unstructured":"Chang K, Chen Y, Zhang X, Zhang W, Xu N, Zeng B, Wang Y, Feng T, Dai B, Xu F, Ye D, Wang C (2023) DPP9 stabilizes NRF2 to suppress ferroptosis and induce sorafenib resistance in clear cell renal cell carcinoma. Cancer Res 83(23):3940\u20133955","journal-title":"Cancer Res"},{"issue":"4","key":"2635_CR69","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.7150\/ijbs.79853","volume":"19","author":"Q Wang","year":"2023","unstructured":"Wang Q, Gao S, Shou Y, Jia Y, Wei Z, Liu Y, Shi J, Miao D, Miao Q, Zhao C, Liu C, Yang H, Xu T, Zhang X (2023) AIM2 promotes renal cell carcinoma progression and sunitinib resistance through FOXO3a-ACSL4 axis-regulated ferroptosis. Int J Biol Sci 19(4):1266\u20131283","journal-title":"Int J Biol Sci"},{"key":"2635_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216963","volume":"593","author":"WJ Chen","year":"2024","unstructured":"Chen WJ, Pan XW, Song X, Liu ZC, Xu D, Chen JX, Dong KQ, Di SC, Ye JQ, Gan SS, Wang LH, Zhou W, Cui XG (2024) Preoperative neoadjuvant targeted therapy remodels intra-tumoral heterogeneity of clear-cell renal cell carcinoma and ferroptosis inhibition induces resistance progression. Cancer Lett 593","journal-title":"Cancer Lett"},{"issue":"1","key":"2635_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07456-9","volume":"16","author":"Y Pan","year":"2025","unstructured":"Pan Y, Liu S, Shu G, Chen M, Fu L, Chen C, Chen Y, Zhuang Q, Xue D, He X (2025) STX17-DT facilitates axitinib resistance in renal cell carcinoma by inhibiting mitochondrial ROS accumulation and ferroptosis. Cell Death Dis 16(1)","journal-title":"Cell Death Dis"},{"key":"2635_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111421","volume":"124","author":"Z Chen","year":"2024","unstructured":"Chen Z, Jia X, Wang Z, Cai Y, Xu A, Han C, Cheng S, Liu M (2024) TRIB3 knockdown increases the sensitivity of clear cell renal cell carcinoma to sunitinib by inducing ferroptosis. Cell Signal 124","journal-title":"Cell Signal"},{"issue":"6","key":"2635_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2025.119989","volume":"1872","author":"Y Su","year":"2025","unstructured":"Su Y, Liu X, Wang D, Li G, Mi X, Zhang Y, Yue S, Zhang Z, Shen T, Tan X (2025) Salinomycin inhibits SREBP1 to sensitize ferroptosis and ameliorate sorafenib resistance in clear cell renal cell carcinoma. Biochim Biophys Acta Mol Cell Res 1872(6)","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"2635_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102356","volume":"54","author":"Y Kong","year":"2022","unstructured":"Kong Y, Akatsuka S, Motooka Y, Zheng H, Cheng Z, Shiraki Y, Mashimo T, Imaoka T, Toyokuni S (2022) BRCA1 haploinsufficiency promotes chromosomal amplification under Fenton reaction-based carcinogenesis through ferroptosis-resistance. Redox Biol 54","journal-title":"Redox Biol"},{"key":"2635_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103739","volume":"85","author":"Y Maeda","year":"2025","unstructured":"Maeda Y, Motooka Y, Akatsuka S, Tanaka H, Mashimo T, Toyokuni S (2025) Iron-catalyzed oxidative stress compromises cancer promotional effect of BRCA2 haploinsufficiency through mitochondria-targeted ferroptosis. Redox Biol 85","journal-title":"Redox Biol"},{"issue":"1","key":"2635_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-022-00337-3","volume":"11","author":"D Feng","year":"2022","unstructured":"Feng D, Zhu W, Shi X, Xiong Q, Li D, Wei W, Han P, Wei Q, Yang L (2022) Spindle and kinetochore-associated complex subunit 3 could serve as a prognostic biomarker for prostate cancer. Exp Hematol Oncol 11(1)","journal-title":"Exp Hematol Oncol"},{"key":"2635_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.858479","volume":"12","author":"D Feng","year":"2022","unstructured":"Feng D, Shi X, Zhang F, Xiong Q, Wei Q, Yang L (2022) Mitochondria dysfunction-mediated molecular subtypes and gene prognostic index for prostate cancer patients undergoing radical prostatectomy or radiotherapy. Front Oncol 12","journal-title":"Front Oncol"},{"issue":"4","key":"2635_CR78","doi-asserted-by":"publisher","first-page":"378","DOI":"10.21147\/j.issn.1000-9604.2024.04.03","volume":"36","author":"H Chen","year":"2024","unstructured":"Chen H, Ao Q, Wang Y, Qian Y, Cheng Q, Zhang W (2024) SOX11 as a potential prognostic biomarker in hepatocellular carcinoma linked to immune infiltration and ferroptosis. Chin J Cancer Res 36(4):378\u201397. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2024.04.03","journal-title":"Chin J Cancer Res"},{"issue":"5","key":"2635_CR79","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1515\/jtim-2024-0023","volume":"12","author":"Y Gao","year":"2024","unstructured":"Gao Y, Li J, Ma M, Fu W, Ma L, Sui Y, Wang Y (2024) Prognostic prediction of m6A and ferroptosis-associated lncRNAs in liver hepatocellular carcinoma. J Transl Intern Med 12(5):526\u2013529","journal-title":"J Transl Intern Med"},{"issue":"15","key":"2635_CR80","doi-asserted-by":"publisher","first-page":"19789","DOI":"10.18632\/aging.203390","volume":"13","author":"B Zheng","year":"2021","unstructured":"Zheng B, Niu Z, Si S, Zhao G, Wang J, Yao Z, Cheng F, He W (2021) Comprehensive analysis of new prognostic signature based on ferroptosis-related genes in clear cell renal cell carcinoma. Aging Albany NY 13(15):19789\u201319804","journal-title":"Aging Albany NY"},{"issue":"1","key":"2635_CR81","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-022-02555-9","volume":"20","author":"Z Sun","year":"2022","unstructured":"Sun Z, Li T, Xiao C, Zou S, Zhang M, Zhang Q, Wang Z, Zhan H, Wang H (2022) Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma. World J Surg Oncol 20(1)","journal-title":"World J Surg Oncol"},{"issue":"10","key":"2635_CR82","doi-asserted-by":"publisher","first-page":"868","DOI":"10.2174\/0109298665255704230920063254","volume":"30","author":"Z Ren","year":"2023","unstructured":"Ren Z, Zhang X, Han J (2023) Expression and prognostic significance of ferroptosis-related proteins SLC7A11 and GPX4 in renal cell carcinoma. Protein Pept Lett 30(10):868\u2013876","journal-title":"Protein Pept Lett"},{"issue":"21","key":"2635_CR83","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1002\/cam4.4716","volume":"11","author":"R Huang","year":"2022","unstructured":"Huang R, Zhang C, Wang X, Zou X, Xiang Z, Wang Z, Gui B, Lin T, Hu H (2022) Identification of FDFT1 as a potential biomarker associated with ferroptosis in ccRCC. Cancer Med 11(21):3993\u20134004","journal-title":"Cancer Med"},{"key":"2635_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.697697","volume":"11","author":"L Chen","year":"2021","unstructured":"Chen L, Wang C, Wang Y, Hong T, Zhang G, Cui X (2021) Functions, roles, and biological processes of ferroptosis-related genes in renal cancer: a pan-renal cancer analysis. Front Oncol 11","journal-title":"Front Oncol"},{"issue":"1","key":"2635_CR85","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-09033-7","volume":"22","author":"S Chen","year":"2022","unstructured":"Chen S, Zhang E, Guo T, Shao J, Wang T, Zhang N, Wang X, Zheng J (2022) A novel ferroptosis-related gene signature associated with cell cycle for prognosis prediction in patients with clear cell renal cell carcinoma. BMC Cancer 22(1)","journal-title":"BMC Cancer"},{"issue":"1","key":"2635_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08559-0","volume":"21","author":"Y Hong","year":"2021","unstructured":"Hong Y, Lin M, Ou D, Huang Z, Shen P (2021) A novel ferroptosis-related 12-gene signature predicts clinical prognosis and reveals immune relevancy in clear cell renal cell carcinoma. BMC Cancer 21(1)","journal-title":"BMC Cancer"},{"issue":"3","key":"2635_CR87","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1007\/s12094-024-03617-y","volume":"27","author":"YB Chen","year":"2025","unstructured":"Chen YB, Yang X, Lv D, Tang LY, Liu YW (2025) A prognostic model constructed by ferroptosis-associated genes (FAGs) in papillary renal cell carcinoma (PRCC) and its association with tumor mutation burden (TMB) and immune infiltration. Clin Transl Oncol 27(3):1232\u20131247","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"2635_CR88","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-11589-5","volume":"23","author":"S Liu","year":"2023","unstructured":"Liu S, Yao Y, Hou M, Mei J, Sun L, Zhang G (2023) Identification and validation of a ferroptosis-related signature for prediction of the prognosis and tumor microenvironment in patients with chromophobe renal cell carcinoma. BMC Cancer 23(1)","journal-title":"BMC Cancer"},{"key":"2635_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24109092","author":"J Zhang","year":"2023","unstructured":"Zhang J, Deng Y, Zhang H, Zhang Z, Jin X, Xuan Y, Zhang Z, Ma X (2023) Single-cell RNA-Seq analysis reveals ferroptosis in the tumor microenvironment of clear cell renal cell carcinoma. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24109092","journal-title":"Int J Mol Sci"},{"key":"2635_CR90","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.929838","volume":"12","author":"T Zhu","year":"2022","unstructured":"Zhu T, Xiao Z, Yuan H, Tian H, Chen T, Chen Q, Chen M, Yang J, Zhou Q, Guo W, Xue K, Xia M, Bao J, Yang C, Duan H, Wang H, Huang Z, Liu C, Zhou J (2022) ACO1 and IREB2 downregulation confer poor prognosis and correlate with autophagy-related ferroptosis and immune infiltration in KIRC. Front Oncol 12","journal-title":"Front Oncol"},{"key":"2635_CR91","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20020913","author":"J Leng","year":"2023","unstructured":"Leng J, Xing Z, Li X, Bao X, Zhu J, Zhao Y, Wu S, Yang J (2023) Assessment of diagnosis, prognosis and immune infiltration response to the expression of the ferroptosis-related molecule HAMP in clear cell renal cell carcinoma. Int J Environ Res Public Health. https:\/\/doi.org\/10.3390\/ijerph20020913","journal-title":"Int J Environ Res Public Health"},{"key":"2635_CR92","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.14506","volume":"10","author":"L Ju","year":"2022","unstructured":"Ju L, Shi Y, Liu G (2022) Identification and validation of a ferroptosis-related lncRNA signature to robustly predict the prognosis, immune microenvironment, and immunotherapy efficiency in patients with clear cell renal cell carcinoma. PeerJ 10","journal-title":"PeerJ"},{"issue":"1","key":"2635_CR93","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-022-01418-2","volume":"15","author":"SY Wei","year":"2022","unstructured":"Wei SY, Feng B, Bi M, Guo HY, Ning SW, Cui R (2022) Construction of a ferroptosis-related signature based on seven lncRNAs for prognosis and immune landscape in clear cell renal cell carcinoma. BMC Med Genomics 15(1)","journal-title":"BMC Med Genomics"},{"issue":"3","key":"2635_CR94","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.3390\/cimb46030123","volume":"46","author":"Y Gong","year":"2024","unstructured":"Gong Y, Zhang C, Li H, Yu X, Li Y, Liu Z, He R (2024) Ferroptosis-related lncRNA to predict the clinical outcomes and molecular characteristics of kidney renal papillary cell carcinoma. Curr Issues Mol Biol 46(3):1886\u20131903","journal-title":"Curr Issues Mol Biol"},{"key":"2635_CR95","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1473203","volume":"15","author":"C He","year":"2024","unstructured":"He C, Li Q, Wu W, Liu K, Li X, Zheng H, Lai Y (2024) Ferroptosis-associated genes and compounds in renal cell carcinoma. Front Immunol 15","journal-title":"Front Immunol"},{"issue":"11-12","key":"2635_CR96","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1007\/s10495-022-01766-5","volume":"27","author":"L Liu","year":"2022","unstructured":"Liu L, Jin H, Dong M, Tian J, Li H, Liu Q, Chen Y, Zou Z (2022) Identification of ferroptosis-related signature with potential implications in prognosis and immunotherapy of renal cell carcinoma. Apoptosis 27(11\u201312):946\u2013960","journal-title":"Apoptosis"},{"key":"2635_CR97","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1182030","volume":"14","author":"Y Wu","year":"2023","unstructured":"Wu Y, Lin Z, Tang X, Tong Z, Ji Y, Xu Y, Zhou Z, Yang J, Li Z, Liu T (2023) Ferroptosis-related gene HIC1 in the prediction of the prognosis and immunotherapeutic efficacy with immunological activity. Front Immunol 14","journal-title":"Front Immunol"},{"key":"2635_CR98","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.670384","volume":"12","author":"F Zhang","year":"2021","unstructured":"Zhang F, Wang X, Bai Y, Hu H, Yang Y, Wang J, Tang Y, Ma H, Feng D, Li D, Han P (2021) Development and validation of a hypoxia-related signature for predicting survival outcomes in patients with bladder cancer. Front Genet 12","journal-title":"Front Genet"},{"issue":"5","key":"2635_CR99","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2021.13042","volume":"22","author":"Y Du","year":"2021","unstructured":"Du Y, Zhao HC, Zhu HC, Jin Y, Wang L (2021) Ferroptosis is involved in the anti-tumor effect of lycorine in renal cell carcinoma cells. Oncol Lett 22(5)","journal-title":"Oncol Lett"},{"key":"2635_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154182","volume":"102","author":"R Yu","year":"2022","unstructured":"Yu R, Zhou Y, Shi S, Wang X, Huang S, Ren Y (2022) Icariside II induces ferroptosis in renal cell carcinoma cells by regulating the miR-324-3p\/GPX4 axis. Phytomedicine 102","journal-title":"Phytomedicine"},{"key":"2635_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2021.145992","volume":"809","author":"W Yangyun","year":"2022","unstructured":"Yangyun W, Guowei S, Shufen S, Jie Y, Rui Y, Yu R (2022) Everolimus accelerates Erastin and RSL3-induced ferroptosis in renal cell carcinoma. Gene 809","journal-title":"Gene"},{"issue":"3","key":"2635_CR102","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/mdr2.70025","volume":"1","author":"Z Yang","year":"2025","unstructured":"Yang Z, Song L, Chen H, Chen Y, Xie Y, Xie J (2025) Exploring the potential anticancer effects of Lobelia chinensis Lour in liver cancer via multiomics analysis. Med Res 1(3):483\u20138. https:\/\/doi.org\/10.1002\/mdr2.70025","journal-title":"Med Res"},{"key":"2635_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155503","volume":"127","author":"D Li","year":"2024","unstructured":"Li D, Wang J, Tuo Z, Yoo KH, Yu Q, Miyamoto A, Zhang C, Ye X, Wei W, Wu R, Feng D (2024) Natural products and derivatives in renal, urothelial and testicular cancers: targeting signaling pathways and therapeutic potential. Phytomedicine 127","journal-title":"Phytomedicine"},{"issue":"3","key":"2635_CR104","doi-asserted-by":"publisher","first-page":"367","DOI":"10.7150\/jca.81027","volume":"14","author":"H Shen","year":"2023","unstructured":"Shen H, Geng Z, Nie X, Liu T (2023) Erianin induces ferroptosis of renal cancer stem cells via promoting ALOX12\/P53 mRNA N6-methyladenosine modification. J Cancer 14(3):367\u2013378","journal-title":"J Cancer"},{"issue":"1","key":"2635_CR105","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3846217","volume":"2022","author":"S Han","year":"2022","unstructured":"Han S, Lin F, Qi Y, Liu C, Zhou L, Xia Y, Chen K, Xing J, Liu Z, Yu W, Zhang Y, Zhou X, Rao T, Cheng F (2022) HO-1 contributes to luteolin-triggered ferroptosis in clear cell renal cell carcinoma via increasing the labile iron pool and promoting lipid peroxidation. Oxid Med Cell Longev 2022(1)","journal-title":"Oxid Med Cell Longev"},{"issue":"2","key":"2635_CR106","doi-asserted-by":"publisher","first-page":"119","DOI":"10.56434\/j.arch.esp.urol.20247702.16","volume":"77","author":"H Zhao","year":"2024","unstructured":"Zhao H, Ding R, Han J (2024) Ginsenoside Rh4 facilitates the sensitivity of renal cell carcinoma to ferroptosis via the NRF2 pathway. Arch Esp Urol 77(2):119\u2013128","journal-title":"Arch Esp Urol"},{"issue":"3","key":"2635_CR107","doi-asserted-by":"publisher","DOI":"10.1111\/cbdd.70071","volume":"105","author":"P Chen","year":"2025","unstructured":"Chen P, Yang J, Chen L, Liu C, Li Z, Long X, Wu J, Wu B, Wu J (2025) Moscatilin induces ferroptosis in clear cell renal cell carcinoma via the JAK-STAT signaling pathway. Chem Biol Drug Des 105(3)","journal-title":"Chem Biol Drug Des"},{"key":"2635_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2025.117531","volume":"504","author":"Z Chen","year":"2025","unstructured":"Chen Z, Li W, Jia B, Yin G, Sun Z, Tong Y, Cheng S, Liu M (2025) Chrysin enhances sunitinib sensitivity in renal cell carcinoma by inducing ferroptosis via targeting PI3K\/Akt\/GPX4 pathway. Toxicol Appl Pharmacol 504","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"2635_CR109","doi-asserted-by":"publisher","DOI":"10.1002\/biof.70016","volume":"51","author":"Z Chen","year":"2025","unstructured":"Chen Z, Han C, Xie H, Chen X, Zhang H, Sun Z, Liu M (2025) 2-undecanone induces ferroptosis via the STAT3\/GPX4 pathway to enhance sensitivity of renal cell carcinoma to sunitinib. BioFactors 51(2)","journal-title":"BioFactors"},{"issue":"4","key":"2635_CR110","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05779-z","volume":"14","author":"J Hao","year":"2023","unstructured":"Hao J, Chen Q, Feng Y, Jiang Q, Sun H, Deng B, Huang X, Guan J, Chen Q, Liu X, Wang Y, Cao P, Feng F, Li X (2023) Combination treatment with FAAH inhibitors\/URB597 and ferroptosis inducers significantly decreases the growth and metastasis of renal cell carcinoma cells via the PI3K-AKT signaling pathway. Cell Death Dis 14(4)","journal-title":"Cell Death Dis"},{"issue":"3","key":"2635_CR111","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1158\/1535-7163.MCT-21-0661","volume":"21","author":"B Kerimoglu","year":"2022","unstructured":"Kerimoglu B, Lamb C, McPherson RD, Ergen E, Stone EM, Ooi A (2022) Cyst(e)inase-rapamycin combination induces ferroptosis in both in vitro and in vivo models of hereditary leiomyomatosis and renal cell cancer. Mol Cancer Ther 21(3):419\u2013426","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"2635_CR112","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1166\/jbn.2022.3250","volume":"18","author":"W Ni","year":"2022","unstructured":"Ni W, Li Y, Liang L, Yang S, Zhan M, Lu C, Lu L, Wen L (2022) Tumor microenvironment-responsive nanodrug for clear-cell renal cell carcinoma therapy via triggering waterfall-like cascade ferroptosis. J Biomed Nanotechnol 18(2):327\u2013342 (PubMed PMID: 35484753)","journal-title":"J Biomed Nanotechnol"},{"issue":"1","key":"2635_CR113","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-024-03419-0","volume":"56","author":"D Lv","year":"2024","unstructured":"Lv D, Xiang Y, Song T, Li J, Chen Y, Huili Y, Shen T (2024) HECTD2 as a target for veratric acid in the regulation of ferroptosis in renal cell carcinoma. Amino Acids 56(1)","journal-title":"Amino Acids"},{"key":"2635_CR114","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-025-00953-1","author":"N Mahmoud","year":"2025","unstructured":"Mahmoud N, Qin X, Bzeih W, Khabibullin D, Alchoueiry M, Safi S, Chami J, Han T, Salem S, Priolo C, Chakraborty AA, Sarosiek KA, Henske EP (2025) BCL-xL dependency in chromophobe renal cell carcinoma. Cancer Gene Ther. https:\/\/doi.org\/10.1038\/s41417-025-00953-1","journal-title":"Cancer Gene Ther"},{"issue":"1","key":"2635_CR115","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-97887-3","volume":"15","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Zhu L, Lin X, Li B, Miu B, Qiu J, Gao S, Liu J (2025) JS-K induces ferroptosis in renal carcinoma cells by regulating the c-Myc-GSTP1 axis. Sci Rep 15(1)","journal-title":"Sci Rep"},{"key":"2635_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2023.106454","volume":"134","author":"H Li","year":"2023","unstructured":"Li H, Deng C, Zhu N, Zhang C, Zeng Q, Qin L (2023) An ultrasensitive GSH-specific fluorescent probe unveils celastrol-induced ccRCC ferroptosis. Bioorg Chem 134","journal-title":"Bioorg Chem"},{"issue":"6","key":"2635_CR117","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.14336\/AD.2023.0502","volume":"14","author":"D Feng","year":"2023","unstructured":"Feng D, Li D, Wu R, Han P (2023) Scientific advancements in drug development and trials for urothelial carcinoma: insights from the 2023 ASCO-GU cancers symposium. Aging Dis 14(6):1953\u20131957","journal-title":"Aging Dis"},{"issue":"2","key":"2635_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2024.101075","volume":"15","author":"W Liao","year":"2025","unstructured":"Liao W, Wang J, Li Y (2025) Natural products based on Correa\u2019s cascade for the treatment of gastric cancer trilogy: current status and future perspective. J Pharm Anal 15(2)","journal-title":"J Pharm Anal"},{"issue":"2","key":"2635_CR119","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrd3252","volume":"10","author":"T Force","year":"2011","unstructured":"Force T, Kolaja KL (2011) Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes. Nat Rev Drug Discov 10(2):111\u2013126 (PubMed PMID: 21283106)","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"2635_CR120","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s00018-025-05742-5","volume":"82","author":"R Zhou","year":"2025","unstructured":"Zhou R, Zhou J, Xiong Y, Su K, Liu C, Cheng B, Wu T (2025) <article-title update=\"added\">Sulfasalazine combined with anti-IL-1\u03b2 mAb induces ferroptosis and immune modulation in oral squamous cell carcinoma. Cell Mol Life Sci 82(1):216. https:\/\/doi.org\/10.1007\/s00018-025-05742-5","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"2635_CR121","doi-asserted-by":"publisher","DOI":"10.1002\/brx2.27","volume":"1","author":"G Cheng","year":"2023","unstructured":"Cheng G, Xie A, Yan Z, Zhu X, Song Y, Chen T (2023) Nanomedicines for Alzheimer\u2019s disease: therapies based on pathological mechanisms. Brain-X 1(3)","journal-title":"Brain-X"},{"issue":"1","key":"2635_CR122","volume":"12","author":"HJ Yu","year":"2025","unstructured":"Yu HJ, Liu JH, Liu W, Niu R, Zhang B, Xiong Y, Liu Y, Wang YH, Zhang HJ (2025) Metal-based nanomedicines for cancer theranostics. Mil Med Res 12(1)","journal-title":"Mil Med Res"},{"key":"2635_CR123","doi-asserted-by":"publisher","DOI":"10.34133\/research.0752","volume":"8","author":"X Tan","year":"2025","unstructured":"Tan X, Wu X, Sheng R, Tao Y, Li W, Liang Y, Gui B, Lu H, Feng D, Chen N, Liu F, Liu L, Ge L (2025) Microbubble-templated immunoactive metal-phenolic capsules for drug delivery and enhanced cancer immunotherapy. Research 8","journal-title":"Research"},{"issue":"1","key":"2635_CR124","doi-asserted-by":"publisher","DOI":"10.1002\/EXP.20240002","volume":"5","author":"X Bai","year":"2025","unstructured":"Bai X, Kang J, Wei S, Wang Y, Liu Y, Yuan B, Lu Q, Li H, Yan J, Yang X, Chang J (2025) A pH responsive nanocomposite for combination sonodynamic-immunotherapy with ferroptosis and calcium ion overload via SLC7A11\/ACSL4\/LPCAT3 pathway. Exploration (Beijing) 5(1)","journal-title":"Exploration (Beijing)"},{"issue":"1","key":"2635_CR125","doi-asserted-by":"publisher","DOI":"10.1002\/EXP.20230117","volume":"5","author":"Y Li","year":"2025","unstructured":"Li Y, Duan Y, Li Y, Gu Y, Zhou L, Xiao Z, Yu X, Cai Y, Cheng E, Liu Q, Jiang Y, Yang Q, Zhang F, Lei Q, Yang B (2025) Cascade loop of ferroptosis induction and immunotherapy based on metal-phenolic networks for combined therapy of colorectal cancer. Exploration (Beijing) 5(1)","journal-title":"Exploration (Beijing)"},{"issue":"3","key":"2635_CR126","first-page":"322","volume":"1","author":"A Lin","year":"2025","unstructured":"Lin A, Zheng K, Jiang A, Huang X, Wang Q, Hajdu A, Li Z, Zhang J, Luo P (2025) The evolving landscape of immunotoxicity: charting mechanisms and future strategies for immune checkpoint inhibitor adverse events. Med Res 1(3):322\u2013358","journal-title":"Med Res"},{"issue":"5","key":"2635_CR127","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.21037\/tau-20-615","volume":"9","author":"D Feng","year":"2020","unstructured":"Feng D, Liu S, Li D, Han P, Wei W (2020) Analysis of conventional versus advanced pelvic floor muscle training in the management of urinary incontinence after radical prostatectomy: a systematic review and meta-analysis of randomized controlled trials. Transl Androl Urol 9(5):2031\u20132045","journal-title":"Transl Androl Urol"},{"issue":"7755","key":"2635_CR128","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","volume":"569","author":"W Wang","year":"2019","unstructured":"Wang W, Green M, Choi JE, Gijon M, Kennedy PD, Johnson JK, Liao P, Lang X, Kryczek I, Sell A, Xia H, Zhou J, Li G, Li J, Li W, Wei S, Vatan L, Zhang H, Szeliga W, Gu W, Liu R, Lawrence TS, Lamb C, Tanno Y, Cieslik M, Stone E, Georgiou G, Chan TA, Chinnaiyan A, Zou W (2019) CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy. Nature 569(7755):270\u2013274","journal-title":"Nature"},{"issue":"1","key":"2635_CR129","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20154-8","volume":"11","author":"E Dai","year":"2020","unstructured":"Dai E, Han L, Liu J, Xie Y, Zeh HJ, Kang R, Bai L, Tang D (2020) Ferroptotic damage promotes pancreatic tumorigenesis through a TMEM173\/STING-dependent DNA sensor pathway. Nat Commun 11(1)","journal-title":"Nat Commun"},{"key":"2635_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102463","volume":"56","author":"X Hao","year":"2022","unstructured":"Hao X, Zheng Z, Liu H, Zhang Y, Kang J, Kong X, Rong D, Sun G, Sun G, Liu L, Yu H, Tang W, Wang X (2022) Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing. Redox Biol 56","journal-title":"Redox Biol"},{"issue":"11","key":"2635_CR131","doi-asserted-by":"publisher","first-page":"7330","DOI":"10.1021\/acs.nanolett.8b03568","volume":"18","author":"C Shi","year":"2018","unstructured":"Shi C, Liu T, Guo Z, Zhuang R, Zhang X, Chen X (2018) Reprogramming tumor-associated macrophages by nanoparticle-based reactive oxygen species photogeneration. Nano Lett 18(11):7330\u20137342","journal-title":"Nano Lett"},{"issue":"1","key":"2635_CR132","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19193-y","volume":"11","author":"PP Yee","year":"2020","unstructured":"Yee PP, Wei Y, Kim SY, Lu T, Chih SY, Lawson C, Tang M, Liu Z, Anderson B, Thamburaj K, Young MM, Aregawi DG, Glantz MJ, Zacharia BE, Specht CS, Wang HG, Li W (2020) Neutrophil-induced ferroptosis promotes tumor necrosis in glioblastoma progression. Nat Commun 11(1)","journal-title":"Nat Commun"},{"issue":"24","key":"2635_CR133","doi-asserted-by":"publisher","first-page":"6338","DOI":"10.1158\/0008-5472.CAN-12-3544","volume":"72","author":"MA Hallett","year":"2012","unstructured":"Hallett MA, Venmar KT, Fingleton B (2012) Cytokine stimulation of epithelial cancer cells: the similar and divergent functions of IL-4 and IL-13. Cancer Res 72(24):6338\u20136343","journal-title":"Cancer Res"},{"key":"2635_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101107","volume":"23","author":"M Dodson","year":"2019","unstructured":"Dodson M, Castro-Portuguez R, Zhang DD (2019) NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol 23","journal-title":"Redox Biol"},{"issue":"7784","key":"2635_CR135","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker K, Hendricks JM, Li Z, Magtanong L, Ford B, Tang PH, Roberts MA, Tong B, Maimone TJ, Zoncu R, Bassik MC, Nomura DK, Dixon SJ, Olzmann JA (2019) The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature 575(7784):688\u2013692","journal-title":"Nature"},{"issue":"1","key":"2635_CR136","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/hep.28251","volume":"63","author":"X Sun","year":"2016","unstructured":"Sun X, Ou Z, Chen R, Niu X, Chen D, Kang R, Tang D (2016) Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology 63(1):173\u2013184","journal-title":"Hepatology"},{"issue":"1","key":"2635_CR137","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01720-0","volume":"8","author":"Y Wang","year":"2023","unstructured":"Wang Y, Hu J, Wu S, Fleishman JS, Li Y, Xu Y, Zou W, Wang J, Feng Y, Chen J, Wang H (2023) Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases. Signal Transduct Target Ther 8(1)","journal-title":"Signal Transduct Target Ther"},{"key":"2635_CR138","volume":"8","author":"J Wang","year":"2025","unstructured":"Wang J, Shao F, Yu QX, Ye L, Wusiman D, Wu R, Tuo Z, Wang Z, Li D, Cho WC, Wei W, Feng D (2025) The common hallmarks and interconnected pathways of aging, circadian rhythms, and cancer: implications for therapeutic strategies. Research Wash DC 8","journal-title":"Research Wash DC"},{"key":"2635_CR139","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.803766","volume":"10","author":"D Feng","year":"2022","unstructured":"Feng D, Shi X, Xiong Q, Zhang F, Li D, Wei W, Yang L (2022) A ferroptosis-related gene prognostic index associated with biochemical recurrence and radiation resistance for patients with prostate cancer undergoing radical radiotherapy. Front Cell Dev Biol 10","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"2635_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e23495","volume":"10","author":"D Feng","year":"2024","unstructured":"Feng D, Tuo Z, Wang J, Ye L, Li D, Wu R, Wei W, Yang Y, Zhang C (2024) Establishment of novel ferroptosis-related prognostic subtypes correlating with immune dysfunction in prostate cancer patients. Heliyon 10(1)","journal-title":"Heliyon"},{"issue":"5","key":"2635_CR141","doi-asserted-by":"publisher","first-page":"455","DOI":"10.21147\/j.issn.1000-9604.2024.05.01","volume":"36","author":"M Wu","year":"2024","unstructured":"Wu M, Liao Y, Tang L (2024) Non-small cell lung cancer organoids: advances and challenges in current applications. Chin J Cancer Res 36(5):455\u2013473","journal-title":"Chin J Cancer Res"},{"key":"2635_CR142","doi-asserted-by":"publisher","DOI":"10.1093\/burnst\/tkae077","volume":"13","author":"Z Wang","year":"2025","unstructured":"Wang Z, Zhao F, Lang H, Ren H, Zhang Q, Huang X, He C, Xu C, Tan C, Ma J, Duan S, Wang Z (2025) Organoids in skin wound healing. Burns Trauma 13","journal-title":"Burns Trauma"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-025-02635-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-025-02635-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-025-02635-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T02:02:36Z","timestamp":1767664956000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-025-02635-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":142,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2635"],"URL":"https:\/\/doi.org\/10.1007\/s00109-025-02635-9","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"assertion":[{"value":"25 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not available.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not available.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}